Regulatory in brief | NSAIDs, codeine, CMDh

22 October 2020 - Deborah Wilkes

The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for Mutual Recognition and Decentralised Procedures for Humans (CMDh) has a new chair.